A carregar...
Challenges of CAR- and TCR-T cell–based therapy for chronic infections
While therapy with T cells engineered with a chimeric antigen receptor (CAR) or a classical T cell receptor (TCR) is revolutionizing cancer treatment, its adoption in infectious diseases has been met with considerable resistance. Can we find its value for the cure of infections?
Na minha lista:
| Publicado no: | J Exp Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Rockefeller University Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7201928/ https://ncbi.nlm.nih.gov/pubmed/32163104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20191663 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|